银丹心脑通软胶囊联合阿司匹林治疗脑梗死后遗症的临床观察

Clinical Observation on Yindan Xinnaotong Capsule Combined with Aspirin in Treatment of Cerebral Infarction Sequelae

目的观察银丹心脑通软胶囊联合阿司匹林治疗脑梗死后遗症的临床疗效。方法将62例符合脑梗死后遗症诊断标准的患者随机分为2组。对照组31例,给予阿司匹林100mg/次,1次/d,口服;治疗组在对照组治疗方法基础上加用银丹心脑通软胶囊,4粒/次,3次/d,口服,两组疗程均为1个月。观察比较两组疗效及不良反应,同时测定治疗前后血脂、血流动力学指标。结果对照组总有效率为64.51%,治疗组总有效率为77.41%,治疗组疗效明显优于对照组(P<0.05);治疗组血脂、血流动力学指标的改善也优于对照组。结论银丹心脑通软胶囊联合阿司匹林治疗脑梗死后遗症效果显著,值得推广。

Objective To observe the clinical efficacy of Yindan Xinnaotong capsule combined with aspirin in treatment of cerebral infarction sequelae. Methods 62 cases of patients with cerebral infarction sequelae were ran- domly divided into the control group（31 cases）and the treatment group（31 cases）. The patients of control group were treated by aspirin, 100 rag/time and 1 time/d orally. The patients of treatment group were treated Yindan Xinnaotong capsule 4/time and 3 times/d orally on the basis of treatment of the control group. The therapy course lasted for 1 month. The clinical efficacy and the changes of blood lipid and hemodynamics were observed. Results The total effective rate of treatment group was 77.41% ,control group was 64.51% ,treatment group had obviously superiority than that of control group（P〈0.05）. The treatment group was better than the control group in impro- ving patients＇ blood fat and hemorheological indices. Conclusion The clinical efficacy of Yindan Xinnaotong cap- sule combined with aspirin in treating cerebral infarction sequelae is remarkable, worthy of promotion.